Treatment of axial spondyloarthritis patients with biologic disease-modifying anti-rheumatic drugs in 2022 - data from the Romanian Registry of Rheumatic Diseases
Objective. The objective of this cross-sectional study was to analyze data available in the Romanian Registry of Rheumatic Diseases (RRBR) in 2022 for axial spondyloarthritis (axSpA) patients treated with biologic disease modifying anti-rheumatic drugs (bDMARDs). Methods. From the RRBR electronic da...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Amaltea Medical Publishing House
2023-12-01
|
| シリーズ: | Romanian Journal of Rheumatology |
| 主題: | |
| オンライン･アクセス: | https://rjr.com.ro/articles/2023.4/RJR_2023_4_Art-04.pdf |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|